Melasma: tratamento e suas implicações estéticas
Melasma is part of a biological phenomenon, developed from exposure to UV rays, use of exogenous hormones, genetic factors, and drugs that cause photosensitization. It is known that the incidence occurs mainly in women of childbearing age. Hyperpigmentation is a skin disease that arises after a cu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Council of Pharmacy
2018-08-01
|
Series: | Infarma: Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://revistas.cff.org.br/?journal=infarma&page=article&op=view&path%5B%5D=2255&path%5B%5D=pdf |
Summary: | Melasma is part of a biological phenomenon, developed from exposure to UV rays, use of exogenous hormones,
genetic factors, and drugs that cause photosensitization. It is known that the incidence occurs mainly in women of
childbearing age. Hyperpigmentation is a skin disease that arises after a cutaneous lesion due to an inflammatory reaction.
Melasma and hyperpigmentation are two relatively frequent conditions, and because of the frequency with which
they resurface after treatment, it is extremely important to know them to obtain essential information of an effective
therapy without resurgence. In this sense, the objective of this study was to perform a literature review on melasma
and hyperpigmentation contemplating the pathophysiology and main treatments used. For this, a study was developed
as exploratory-descriptive qualitative research carried out in international journals from November 2016 to April
2017. It is concluded that the treatment protocols have progressed in recent years. However, the actual pathogenesis
of melasma remains somewhat unsatisfactory and that topical agents and systems that use laser sometimes induce
improvement of pigmentation and not total elimination of the lesion. |
---|---|
ISSN: | 0104-0219 2318-9312 |